Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ispinesib in Advanced Hepatocellular Carcinoma
NCT00095992Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Mar 2005
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ispinesib in hepatocellular carcinoma (HCC), sponsored by Canadian Cancer Trials Group. Started Mar 2005; status: completed.
02
Drugs
ispinesib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00095992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095992.